Skip to main content

Table 1 Characteristic features of BC female patients

From: Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer

 

BC patients

Percentage

Age

≥ 40

48%

< 40

52%

Grade

I

8%

II

64%

III

28%

Histological type

Ductal

92%

Lobular

28%

Molecular subtype

Luminal A

52%

Luminal B

12%

HER2 enriched

8%

TNBC

28%

ER status

Positive

64%

Negative

36%

PR status

Positive

56%

Negative

44%

HER-2 status

Positive

16%

Negative

84%

Lymphatic involvement

Yes

60%

No

40%

Proliferative index (Ki-67)

High (> 14%)

80%

Low (< 14%)

20%